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Abstract
Tuberculosis (TB) has long been recognized as a major public health
problem. The rate of TB is high in immigrants and the frequency of drug
resistance is increasing. A major reason for the development of resistant
infections as well as relapse is poor adherence to TB treatment. In response to
this problem, direct observed therapy (DOT) was introduced to the TB program
in Santa Clara County in 1993. The purpose of this study is to compare the
completion rates, relapse rates, and sputum conversion rates between a DOT
group and a non-DOT group of Vietnamese TB patients. A chart review was
completed with a convenience sample of 25 records of DOT patients and 25
records of non-DOT patients. Frequencies and percentages were used to analyze
the completion rates and the relapse rates. The results show that the completion
of therapy rate was 16% higher in the DOT group and the relapse rate was 8%
lower. A t-test indicated that the sputum conversion rate was significantly more
rapid in the DOT group than in the non-DOT group (p <.05). It appears that
Vietnamese TB patients benefit from the DOT program.
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Evaluation of The Effectiveness of a Direct Observed Therapy Program
With Vietnamese Tuberculosis Patients
Tuberculosis (TB) has regained the attention of the medical community
over the last decade as a major public health concern. Although TB affects
many segments of society in the United States (U.S.), it is of special concern
for people from endemic countries. According to the Centers for Disease
Control and Prevention (CDC) (1994), people from Vietnam, Mexico,
Philippines, China, Haiti, India, and Korea account for roughly two-thirds of the
TB cases among foreign-born people in the U.S. In 1994, of the 7,627 foreign
born residents with TB, 869 (11.4%) were from Vietnam (CDC, 1994). In
California, the rate of TB in Santa Clara County (SCC) has steadily increased
in recent years. In 1996, with a rate of 18.2 TB cases per 100,000 persons, the
county is far from meeting the national Year 2000 objective of 3.5 cases per
I 00,000. In 1995, SCC had the 7th highest rate of TB among reporting
jurisdictions in California. By 1996, the county ranked 5th, with a TB rate
higher than California ( 18.2 vs. 12.17). Among 296 TB cases reported by
ethnicity in SCC in 1996, the Vietnamese ranked number one, with 103 cases
(35%) (Public Health Report, 1997).
In response to the rising incidence of TB, the County Health Department
began a program of direct observed therapy (DOT) in 1993 (California TB
Control Report, 1993 ). DOT is a procedure in which health care workers watch
or assist TB patients as they take their medication. At the same time, the health
care worker is available to answer the patient's questions about TB or the TB
therapy, and to help ·resolve any problems the patient may be having with the
disease or treatment (Myers, 1996). DOT may be either clinic or field-based in
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the home, school, workplace, shelter, park, or other convenient place for
patients. If a patient fails to keep an appointment for DOT, the health care
worker begins to look for him or her (Myers, 1996). In SCC, public and private
primary care providers may refer their TB patients to the DOT program or keep
them in self-administered therapy.
Pw:pose
The purpose of this study is to examine the effects of a DOT program
as measured by client outcomes using an ex-post facto correlation research
design to analyze the relationship between the completion-of-therapy rates,
relapse rates, and sputum conversion rates for a DOT group and a non-DOT
group of Vietnamese TB patients.
Hypotheses
'~

Three hypotheses consistent with outcomes pertinent to this client
population and the purpose of the study were tested.
Hypothesis 1. Completion-of-therapy rates will be higher in the DOT
group than in the non-DOT group.
Hypothesis 2. Relapse rates will be lower in the DOT group than in the
non-DOT group.
Hypothesis 3. Sputum conversion (from positive to negative) will occur
more rapidly in the DOT group than in the non-DOT group.
Background and Literature Review
Although effective drugs exist for treating TB, it is difficult to ensure
completion of treatment. Cultural factors, such as misconceptions about
appropriate treatment methods, in combination with other barriers, may
adversely affect adherence and lead to improper uses of TB medication
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(Sumatojo, 1993). Poor adherence to treatment may contribute to the emergence
of drug-resistant bacilli (Van-Si, 1992, p. 24). Some patients may not fully
understand their condition, comprehend its significance, or be aware of
appropriate treatment (p. 24). Differences between patients and providers'
understandings of illnesses can interfere with adherence to treatment (Cohen,
1994). Patients may be reluctant to seek treatment, might not take TB
medication as prescribed, and may have difficulty understanding explanations
offered by health care personnel due to misconceptions about TB,
communication barriers, or fear of being socially stigmatized. Previous research
has shown that misconceptions about TB and other barriers to adherence are
widespread in many different groups in the U.S., including the Vietnamese
population (Carey, Oxtoby, Nguyen, Huynh, Morgan, & Jeffery, 1997).
Vietnamese have traditionally dealt with illness through self-care and
self-medication. When illness does occur, they typically practice self-care:
coining, cupping, pinching, or using herbal medicines before seeking
professional help (Mueke, 1990). In addition, self-medication is the typical
medical behavior in Vietnam (Mueke, 1990). In Vietnam, a prescription to
purchase medicine at a drug store is not needed. This may partially explain the
increasing resistance of TB bacillus to several commonly used antibiotics
(Nguyen, 1989). Vietnamese tend to define their health problem in terms of
physical symptoms and to seek symptomatic treatment. When symptoms are
relieved, or "cured," they are likely to discontinue the treatment (Hoang, 1991 ).
Additionally, most Vietnamese believe that Western medicines are "hot," too
strong, or are inappropriate for the Vietnamese. A typical way to avoid the
problem of "hot" medicine is to reduce the recommended dosage or to stop
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taking the medicine prematurely (Waxler-Morrison, 1990, p. 196). It is difficult
to convince Vietnamese patients that long-term medical treatment (such as TB
treatment) is beneficial, particularly when there are no apparent symptoms. The
practice of reduced dosage and shortened treatment have contributed to
antituberculosis drug-resistance problems in the U.S. (Hoang, 1991). Based on
the California TB Control Report 1992, an estimated 590 (11 %) of the 5,273
total TB patients reported in 1991 did not complete appropriate treatment and
had an increased risk of developing drug resistance and transmitting drugresistant strains to others.
Keane ( 1995) conducted a study of TB prevalence in Vietnamese
emigrants. The study aimed to describe the International Organization for
Migration (IOM) TB screening and treatment program in Ho Chi Minh City
(Vietnam) and to review the prevalence of TB and treatment outcomes in a
cohort of Vietnamese emigrants and refugees prior to their departure (from
November 1, 1992 to June 1, 1993). The report confirms the efficacy of short
course (6 month) chemotherapy coupled with DOT treatment for 265 TB
patients, in the -context of one of the largest screening programs for prospective
emigrants.
In Tarrant County, Texas, a program of universal DOT for TB (all TB
patients were enrolled in the DOT program) was initiated in November 1986 in
response to the development of drug-resistant infection and increasing relapse
rates. A study was conducted to evaluate the effect of the program on the rates
of primary and acquired drug resistance and relapse among patients with TB
(Weis, Slocum, Blais, King, Lunn, Matney, Gomes, & Foresman, 1994). The
authors analyzed records for all patients with positive cultures for
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mycobacterium TB in Tarrant County from January 1, 1980 through December
31, 1992. Through October 1986, patients received a traditional, unsupervised
drug treatment. Beginning in November 1986, nearly all patients received
therapy under direct observation by health care personnel. A total of 407 cases
of TB in which patients received traditional treatment for TB (January 1980
through October 1986) were compared with 581 cases of TB in which therapy
was directly observed (November 1986 through December 1992). Despite
higher rates of intravenous drug use and homelessness and an increasing
incidence of TB during this 13-year period, the frequency of primary drug
resistance decreased from 13.0% to 6.7% after the introduction of DOT, and the
frequency of acquired resistance declined from 14.0% to 2.1 %. The relapse rate
decreased from 20.9% to 5.5% and the number of relapses with multidrugresistant organisms decreased from 25 to 5. The study indicated that the
administration of therapy for TB infection under direct observation leads to
significant reductions in the frequency of primary drug resistance, acquired drug
resistance, and relapse.
Community based DOT for TB control was examined by Chaulk,
Moore-Rice, Rizzo, Chaisson, O'Brien, and Jacobs (1995) in Baltimore, MD.
Comparisons were done with prior rates and with five other cities that had high
rates of TB. Results indicated that since 1981, Baltimore experienced the
greatest decline in TB incidence: 35.6 cases per 100,000 population in 1981 and
17.2 cases per 100,000 population in 1992, a 51. 7% reduction. The city fell
from the 61h highest rate for TB nationally in 1981 to 28 th in 1992. Since 1985,
TB incidence increased 35.3% in a five-city cohort, but declined 29.5% in
Baltimore. From 1986 through 1992, Baltimore's DOT-managed cases had the
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highest sputum conversion rates from positive to negative at 3 months and the
highest completion rates for standard anti-TB therapy when compared with the
five cities. Disease relapse rates remained low, even among HIV-infected
patients. The authors concluded that Baltimore experienced a substantial decline
in TB following implementation of community-based DOT, despite high rates
of medicosocial risk factors. DOT also facilitated high treatment completion
rates and bacteriologic evidence of cure.
The cost of DOT has been cited as a reason for not implementing DOT
programs widely (Weis et al., 1994). The average cost of a non-DOT TB case
with 6-month TB treatment is $12,672, compared to $13,515 for 6-month TB
treatment of a DOT TB case (Moore, Chaulk, Griffiths, Cavalcante, &
Chaisson, 1996). Although this is an increase of about $1,000 over the baseline
direct cost of DOT, it compares favorably to the average cost of treating
multidrug-resistant TB; $230,400, with a range from $100,000 to $500,000
(Moore et al., 1996).
Other studies find similar efficacy rates with DOT programs (Schaaf,
1996; Nitta, 1996; Houston & Fanning, 1994; McDonald, Menon, & Reichman,
1982). All recommend that the high cost of treating multi-drug resistant TB
patients and the danger of spreading resistant organisms make prevention
increasingly important. More emphasis should be placed on DOT to cure newly
diagnosed infectious drug-sensitive TB patients.
Nonadherence to medication regimens has historically been among the
most challenging problems in TB management. According to Moore et al.
( 1996), a variety of factors are known to influence adherence, including the
complexity and duration of treatment regimens, drug side-effects, cost, and
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access to health care. Factors, such as age, gender, race, level of education, and
substance abuse that influence adherence to TB treatment were studied by
Sumatojo (1993). Studies were conducted in different high risk populations of
TB, including those with AIDS, HIV infection, homelessness, and substance
abuse (Alwood, Keruly, Moore-Rice, Stanton, Chaulk, & Chaisson, 1994;
Millard, Cegielski, Wing, Silver, Cohn, & Barbaro, 1994; Schulger, Ciotoli,
Cohen, Johnson, Rom, & Bray, 1995; Wilkinson, Davies, & Connolly, 1996).
The results show that a DOT program is capable of achieving a high degree of
success in a population at high risk for noncompliance. No study about the
effect of DOT on adherence to TB treatment of the Vietnamese population was
found.
Methodology
Sample and Setting
This study used a structured retrospective review of 96 charts of
Vietnamese TB patients who had been followed by the Public Health
Department in Santa Clara County. The criteria for sample selection included
Vietnamese TB patients who were: (a) 18 years or older, (b) had been diagnosed
with pulmonary TB only (with positive culture for mycobacterium TB), and (c)
had been initially prescribed with all four anti-TB medicines (isoniazid [INH],
rifampin [RIF], pyrazinamide [PZA], and ethambutol [EMB]), and (d) had
records that had been completed between December 31, 1994 and December 31,
1997. Patients with a history of AIDS, cancer, diabetes, renal disease,
cardiovascular disease, leprosy, or other chronic diseases were excluded. Patients
who were diagnosed with extrapulmonary or both pulmonary and
extrapulmonary TB were also excluded.
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Procedure
Institutional Review Board clearance from San Jose State University and
written permission from the Director of Public Health Nursing of Santa Clara
County were obtained for this study prior to commencing data collection. Patient
records were selected by hand and were chosen by the investigator according to
common Vietnamese surnames. Records were selected according to the criteria
until the sample size was achieved with 25 records of DOT patients and 25
recor~s of non-DOT patients. The sample was one of convenience and was not
randomized.
Data obtained from patient records were recorded on a 17 item chart
review form designed by the investigator. Demograplµc data included age and
gender to better describe the sample and possibly guide future research.
Sensitivity or resistance was recorded for all TB medications in order to identify
drug-resistant subjects. A multidrug-resistant (MDR) organism was defined as an
isolate demonstrating resistance to at least two of the following drugs: isoniazid
rifampin, ethambutol, or streptomycin. Primary resistance was defined as
resistance to one or more drugs present on the first sensitivity test for which
results were available. Acquired resistance was defined as resistance that was not
present on the initial sensitivity testing but that developed during or after
treatment. The date of treatment initiation, end date, and length of treatment (in
months) were collected to compare the completion rate and the length of
treatment of the DOT group and non-DOT group. The relapse date with or
without acquired drug-resistance was noted in order to compare the relapse rates.
A relapse in this study was defined as a positive culture for mycobacterium TB
in a patient who had previously completed an adequate course of therapy. A
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relapse during therapy was defined as a positive culture in a patient currently
under treatment who had been culture-negative for a minimum of 4 months with
at least three negative cultures. A drug-resistant relapse was defined as a positive
culture for drug-resistant mycobacterium TB in a patient in whom the definition
of a relapse was met. The sputum conversion date (the date the sputum culture
converted to negative) and length of sputum conversion (in weeks) from the date
TB treatment was started to the date sputum converted to negative were recorded
to compare the sputum conversion rate between the two groups. The sites where
patients had medical care and the sites where therapy was observed were also
recorded.
Results
The chart review was completed with the 50 patient records included in
the study. Table 1 displays demographic data for the sample. Patient ages ranged
from 20 to 87 years, with 29 males and 21 females. Twenty-eight patients (56%)
underwent medical care at private medical doctor (PMD) offices, 17 patients
(38%) were treated at a TB clinic, and 3 patients (6%) had medical care at
county medical clinics. Of these 50 patients, 9 ( 18%) were resistant to anti-TB
drugs.
Non-DOT Group
Among the 25 patients in the non-DOT group, 13 were males and 12
were females. Ages ranged from 20 to 87 years, with a mean age of 41.88 years.
Of the 25 patients, 20 (80%) were under medical care of PMDs, 2 (8%) were
treated at various county medical clinics, and 3 (12%) were treated at the county
TB clinic. Two of the patients (8%) were resistant to anti-TB drugs and one of
these patients was a multidrug-resistant TB case.
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DOT Group
There were 25 patients in the DOT group: 16 males and 9 females. Ages
ranged fro~ 21 to 81 years, with a mean age of 39.72 years. Eight patients
(32%) were under medical care of PMDs, one (4%) was treated at the county
medical clinic and 16 (64%) were under medical care at the TB clinic. Seven
patients (28%) were resistant to anti-TB drugs and two of them (8%) were
multidrug-resistant TB cases.
Completion of Therapy Rate
In the non-DOT group, 21 patients (84%) completed the TB treatment
and 4 patients ( 16%) were lost to follow up, compared to 25 patients ( 100%)
who completed the TB treatment in the DOT group. No lost-to-follow up cases
were identified in the DOT group (see Table 2). Frequency and percentage were
used to analyze the results. The statistics showed that the completion-of-therapy
rate was 16% higher in the DOT group, supporting the first hypothesis:
completion-of-therapy rate was higher in the DOT group than in the non-DOT
group.
Relapse Rate
Two patients (8%) in the non-DOT group relapsed after completion of
TB treatment; one was an acquired multidrug-resistance relapse. This compared
to no relapses identified in the DOT group (Table 2). These results support the
second hypothesis: the relapse rate was lower in the DOT group than in the nonDOT group.
Sputum Conversion Rate
In the non-DOT group, the length of time to sputum conversion ranged
from 4 to 16 weeks with the mean of I 0.29 weeks (S.D.

= 2.80) (Table 3).
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the DOT group, the sputum conversion ranged from 2 to 7 weeks with the mean
of 4.72 weeks (S.D. = 1.77) (Table 3). At-test was used to compare the means
between the two groups t

= 8.200; df = 44; p < .05). There was a statistically

significant difference between the DOT group and the non-DOT group in the
achievement of sputum conversion (p = 0.00). These results indicate that the
DOT program has a significant impact on how rapidly the patient can
accomplish sputum conversion. This supports the third hypothesis: sputum
conversion occurred more rapidly in the DOT group than in the non-DOT group.
Discussion
Consistent with the findings of other investigators in different populations
(Alwood et al., 1994; Chaulk et al., 1995; Houston & Fanning, 1994; Keene,
1995; Millard et al., 1994; Nitta, 1996; Schaaf, 1996; Schulger, 1995; Weis et
al., 1994; Wilkinson, Davies, & Connolly, 1996), the results of this study
indicate that a DOT program has a significant impact on the completion rate,
relapse rate, and sputum conversion rate of Vietnamese TB patients. This occurs
despite the higher rate of drug resistant cases in the DOT group (28% vs 8%).
It appears that despite all the differences in culture, health beliefs, and
health practices, the Vietnamese TB clients benefit from the DOT program. The
DOT program apparently provides sufficient support and encouragement to
complete TB treatment. The investigator found that the DOT patients were
followed more closely by primary care providers with visits at least once a
month, compared to every 2 to 3 months in the non-DOT group. In the DOT
group, blood tests, pulmonary radiography, and sputum examinations were
ordered as recommended by CDC guidelines to measure the progress of patients
which were not regularly done in the non-DOT group. These factors may
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contribute to the successful treatment of TB patients. Treatment not only benefits
the individual patient, but also benefits the public at large as infectious cases are
cured and sources of infection are removed from the community. Promoting the
use of effective chemotherapy and monitoring adherence to treatment are
essential for treatment to be successful.
The particular nature of the setting in one public health district office and
one population with a small sample size limits generaliz.ation. However, the
results are promising and need to be followed up with additional studies. The
rapidly growing population and increasingly diverse population of TB patients
poses a real challenge to primary care providers in treating TB. Future research
of diverse populations in various geographic location~ and in a larger sample is
needed to further identify the effectiveness of a DOT program.
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Table I
Demographic

Data

(N
Frequency

Non-DOT Group

DOT Group

Combined Group

(n = 25)

= 50)
Percent

Frequency

(n

Percent

Frequency

= 25)
Percent

Gender
Male

29

58

16

64

13

52

Female

21

42

9

36

12

48

20-29

13

26

9

36

4

16

30-39

14

28

4

16

IO

40

40-49

10

20

5

20

5

20

50-59

6

12

4

16

2

8

60-69

4

8

2

8

2

8

2

0

0

4

4

4

Age

70-79
2

4

9

18

1

28

INH

6

12

5

20

4

Multi-drug

3

6

2

8

4

PMD

28

56

8

32

20

80

TB Clinic

19

38

16

64

3

12

3

6

4

2

8

80-89

Drug Resistance

2

8

Treatment Sites

County Clinic

18

19
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Table 2
Completion of Therapy Rate and Relimse Rate
Combined Group

DOT Group

Non-DOT Group

(N= 50)

(n = 25)

(n = 25)

Frequency

Percent

Frequency

Percent

Frequency

Percent

46

92

25

IOO

21

84

2

4

0

0

2

8

2

0

0

4

2

0

0

4

Complete to
Treatment
Total Relapse
Drug-Resistant
Relapse
Non-Drug
Resist. Relapse

Table 3
Sputum Conversion Rate - Weeks
N

Range

Mean

Standard

Deviation
Non-DOT Group

21.0

4 to 16

I0.29

2.80

DOT Group

25.0

2 to 7

4.72

1.77

